6,502
edits
Changes
→Drugs in This Group
* '''D'''ermatitis (dexamethasone)
* '''D'''ermatitis (dexamethasone)
Potency of the drug increases as you go down the list. "Helping pain management" relates to a mainly anti-inflammatory action; "treating bad dermatitis" relates to a mainly immuno-suppressive effect.
Potency of the drug increases as you go down the list. "Helping pain management" relates to a mainly anti-inflammatory action; "treating bad dermatitis" relates to a mainly immuno-suppressive effect.
Methylprednisolone acetate and triamcinolone acetonide are suitable for intra-articular used. Methylprednisolone acetate is rapidly metabolised to methylprednisolone. Although levels within the joint are maintained for up to 39 days, by 24 hours there is a very low serum concentration of the drug. This steroid has adverse affects on articular cartilage. Triamcinolone acetonide levels in the plasma are higher and maintained for longer, but the drug is undetectable in the joint two weeks post-treatment. It does not have effects on bone remodelling or fragility.
==Clinical Uses==
==Clinical Uses==